Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer
Clinical trial NCT00689702 · UNKNOWN
Trial details
- NCT number
- NCT00689702
- Sponsor
- Institute of Oncology Ljubljana
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2009-04-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.